Tesamorelin has two Phase III lipodystrophy trials (LIPO-010 and CTR-1011), pooled analyses across 816 participants, the Stanley 2019 Lancet HIV NAFLD trial, the Stanley 2014 JAMA abdominal-fat trial, and mechanistic transcriptomic and proteomic follow-up papers
We are moving beyond BMI and simple weight loss goals toward a more holistic, complication-centric approach that treats obesity as a chronic disease (Adiposity-Based Chronic Disease or ABCD)
Mitchell JL, Lyons HS, Walker JK et al (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
Which part of the catalytic cycle is rate-limiting for glutaredoxin catalysis
With a personalised assessment, our practitioners can determine the appropriate dosage and frequency based on your individual needs
In contrast, the fluorescence signals in the paws of SP group were weak during the 24 h observation